Media Advisory - Scientists Deliver on Stem Cell Therapy for Pulmonary Hypertension



    MONTREAL, June 17 /CNW Telbec/ - The Jewish General Hospital's Centre for
Pulmonary Vascular Disease is pleased to invite you to attend the presentation
of a promising study on genetically modified stem cells for the treatment of
pulmonary hypertension.
    Media representatives are invited to a news conference for the
presentation of these results. The conference will take place on Thursday,
June 19, 2008, at 10 a.m. at the Jewish General Hospital, 3999 Côte
Sainte-Catherine, Montreal.

    
    WHO:    Dr. Jacques Galipeau, Hematologist and stem cell researcher
            Jewish General Hospital

            Dr. David Langleben, Director, Centre for Pulmonary Vascular
            Disease
            Jewish General Hospital

            Two patients who were treated with their own gene-modified stem
            cells

    WHAT:   Scientists deliver on stem cell therapy for pulmonary
            hypertension

    WHERE:  Jewish General Hospital
            Lady Davis Institute for Medical Research
            Bloomfield Lecture Hall
            3999 Côte Ste-Catherine
            Montreal, QC H3T 1E2

    WHEN:   Thursday, June 19, 2008, 10 a.m.

    Parking will be made available in the Visitors Parking Lot located on
    Légaré Street.
    




For further information:

For further information: Glenn J. Nashen, Director; Reena Kudhail,
Communications Specialist Public Affairs & Communications, Jewish General
Hospital, (514) 340-8222 x 4120, rkudhail@jgh.mcgill.ca; JGH.ca

Organization Profile

Jewish General Hospital

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890